Market Research Logo

Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (Research, Clinical Diagnostics) - Global Forecast to 202

Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (Research, Clinical Diagnostics) - Global Forecast to 2024

“The increasing adoption of targeted therapy over traditional therapy is expected to drive the overall growth of the immuno-oncology assays market.”
The immuno-oncology assays market is expected to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period. The immuno-oncology assays market is driven primarily by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. However, the high cost of immunotherapy treatment and the high attrition rate in the product development cycle are the major factors that are expected to restrain the growth of this market during the forecast period.

“The lung cancer segment is expected to grow at the highest CAGR during the forecast period.”
Based on indication, the immuno-oncology assays market is segmented into lung cancer, colorectal cancer, melanoma, bladder cancer, and other cancers. The lung cancer segment is expected to be the fastest-growing segment during the forecast period, as major players are focusing on immuno-oncology research for lung cancer owing to its increasing incidence.

“Asia Pacific projected to grow at the highest CAGR during the forecast period.”
The Asia Pacific is projected to record the highest growth rate during the forecast period. Factors such as growing number of CROs in the region, increasing awareness about early detection of cancer, and the shift of manufacturers’ and suppliers’ focus from developed economies to emerging economies, such as India and China are driving the growth of this regional segment.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the immuno-oncology assays market.
By Company Type: Tier 1: 18%, Tier 2: 39%, and Tier 3: 43%
By Designation: C-level Executives: 25%, Directors: 20%, and Others: 55%
By Region: North America: 40%, Europe: 27%, APAC: 20%, and RoW: 13%

The immuno-oncology assays market comprises major providers such as Thermo Fischer Scientific (US), Roche Diagnostics (Switzerland), Agilent Technologies (US), and Illumina (US). The study includes an in-depth competitive analysis of these key players in the immuno-oncology assays market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:
The market study covers the immuno-oncology assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, technology, application, indication, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall immuno-oncology assays market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS COVERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • PRIMARY DATA
      • KEY DATA FROM PRIMARY SOURCES
      • KEY INDUSTRY INSIGHTS
    • SECONDARY DATA
      • KEY DATA FROM SECONDARY SOURCES
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • IMMUNO-ONCOLOGY ASSAYS: MARKET OVERVIEW
    • NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT AND COUNTRY (2018)
    • IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION (2018 VS. 2024)
    • IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY (2018 VS. 2024)
    • GEOGRAPHICAL SNAPSHOT OF THE IMMUNO-ONCOLOGY ASSAYS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
  • IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT
    • INTRODUCTION
      • Table IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
    • CONSUMABLES
      • CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE IMMUNO-ONCOLOGY ASSAYS MARKET DURING THE FORECAST PERIOD
        • Table IMMUNO-ONCOLOGY ASSAYS MARKET FOR CONSUMABLES, BY REGION, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2016-2024 (USD MILLION)
    • SOFTWARE
      • THE NEED TO DELIVER ACCURATE AND TIMELY ANALYSIS OF DIAGNOSTIC TESTS HAS RESULTED IN THE INCREASED ADOPTION OF SOFTWARE
        • Table IMMUNO-ONCOLOGY ASSAYS MARKET FOR SOFTWARE, BY REGION, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR SOFTWARE, BY COUNTRY, 2016-2024 (USD MILLION)
  • IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
    • PCR
      • EMERGENCE OF ADVANCED PCR TECHNOLOGIES TO SUPPORT MARKET GROWTH
        • Table IMMUNO-ONCOLOGY ASSAYS MARKET FOR PCR, BY REGION, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR PCR, BY COUNTRY, 2016-2024 (USD MILLION)
    • IMMUNOASSAY
      • IMMUNOASSAYS HAVE THE POTENTIAL TO REDUCE CANCER MORTALITY RATE BY FACILITATING THE DIAGNOSIS OF CANCER IN THE EARLY STAGE
        • Table IMMUNO-ONCOLOGY ASSAYS MARKET FOR IMMUNOASSAY, BY REGION, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR IMMUNOASSAY, BY COUNTRY, 2016-2024 (USD MILLION)
    • NGS
      • NGS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
        • Table IMMUNO-ONCOLOGY ASSAYS MARKET FOR NGS, BY REGION, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR NGS, BY COUNTRY, 2016-2024 (USD MILLION)
    • FLOW CYTOMETRY
      • FLOW CYTOMETRY PLAYS A CRITICAL ROLE IN CLINICAL RESEARCH STUDIES
        • Table IMMUNO-ONCOLOGY ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2016-2024 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table IMMUNO-ONCOLOGY ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016-2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016-2024 (USD MILLION)
  • IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION
    • INTRODUCTION
      • Table IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION, 2016-2024 (USD MILLION)
    • LUNG CANCER
      • INCREASING R&D ACTIVITIES ON LUNG IMMUNO-ONCOLOGY ASSAYS IS A KEY MARKET DRIVER
        • Table IMMUNO-ONCOLOGY ASSAYS MARKET FOR LUNG CANCER, BY REGION, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR LUNG CANCER, BY COUNTRY, 2016-2024 (USD MILLION)
    • COLORECTAL CANCER
      • HIGH SUCCESS RATE OF IMMUNO-ONCOLOGY ASSAYS IN CRC TREATMENT DECISIONS TO DRIVE MARKET GROWTH
        • Table IMMUN0-ONCOLOGY ASSAYS MARKET FOR COLORECTAL CANCER, BY REGION, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUN0-ONCOLOGY ASSAYS MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2016-2024 (USD MILLION)
    • MELANOMA
      • GROWING CASES OF MELANOMA TO DRIVE MARKET GROWTH
        • Table IMMUN0-ONCOLOGY ASSAYS MARKET FOR MELANOMA, BY REGION, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUN0-ONCOLOGY ASSAYS MARKET FOR MELANOMA, BY COUNTRY, 2016-2024 (USD MILLION)
    • BLADDER CANCER
      • BLADDER CANCER SEGMENT TO WITNESS SLOWER GROWTH OWING TO THE LIMITED ADOPTION OF IMMUNO-ONCOLOGY ASSAYS
        • Table IMMUN0-ONCOLOGY ASSAYS MARKET FOR BLADDER CANCER, BY REGION, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUN0-ONCOLOGY ASSAYS MARKET FOR BLADDER CANCER, BY COUNTRY, 2016-2024 (USD MILLION)
    • OTHER CANCERS
      • Table IMMUNO-ONCOLOGY ASSAYS MARKET FOR OTHER CANCERS, BY REGION, 2016-2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR OTHER CANCERS, BY COUNTRY, 2016-2024 (USD MILLION)
  • IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
    • RESEARCH APPLICATIONS
      • RISING PROMINENCE OF BIOMARKER-BASED DRUG DEVELOPMENT AND CLINICAL TRIALS TO DRIVE THE RESEARCH APPLICATIONS MARKET
        • Table IMMUNO-ONCOLOGY ASSAYS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2016-2024 (USD MILLION)
    • CLINICAL DIAGNOSTICS
      • BENEFITS OF IMMUNO-ONCOLOGY ASSAYS ARE DRIVING ITS ADOPTION IN CLINICAL DIAGNOSTICS
        • Table IMMUNO-ONCOLOGY ASSAYS MARKET FOR APPLICATIONS, BY CLINICAL DIAGNOSTICS, 2016-2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2016-2024 (USD MILLION)
  • IMMUNO-ONCOLOGY ASSAYS MARKET, BY REGION
    • INTRODUCTION
      • Table IMMUNO-ONCOLOGY ASSAYS MARKET, BY REGION, 2016-2024 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION, 2016-2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
      • US
        • Table US: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
        • Table US: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
        • Table US: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION, 2016-2024 (USD MILLION)
        • Table US: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
      • CANADA
        • Table CANADA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
        • Table CANADA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
        • Table CANADA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION, 2016-2024 (USD MILLION)
        • Table CANADA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
    • EUROPE
      • RISING FOCUS ON BIOMARKER DEVELOPMENT IN SEVERAL EU COUNTRIES TO SUPPORT MARKET GROWTH
        • Table EUROPE: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
        • Table EUROPE: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
        • Table EUROPE: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION, 2016-2024 (USD MILLION)
        • Table EUROPE: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
    • ASIA PACIFIC
      • INCREASING DEMAND FOR BETTER HEALTHCARE SERVICES IN DEVELOPING ECONOMIES WILL CONTRIBUTE TO MARKET GROWTH
        • Table APAC: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
        • Table APAC: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
        • Table APAC: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION, 2016-2024 (USD MILLION)
        • Table APAC: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
      • Table ROW: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
      • Table ROW: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION, 2016-2024 (USD MILLION)
      • Table ROW: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • VENDOR BENCHMARKING
      • Table VENDOR BENCHMARKING BY GROWTH STRATEGY
    • COMPETITIVE LEADERSHIP MAPPING
      • VISIONARY LEADERS
      • INNOVATORS
      • DYNAMIC DIFFERENTIATORS
      • EMERGING COMPANIES
    • MARKET RANKING ANALYSIS, 2017
    • COMPETITIVE SITUATION AND TRENDS
      • COLLABORATIONS
        • Table COLLABORATIONS, 2016-2018
      • PRODUCT LAUNCHES
        • Table PRODUCT LAUNCHES, 2016-2018
      • ACQUISITIONS
        • Table ACQUISITIONS, 2016-2018
      • EXPANSIONS
        • Table EXPANSIONS, 2015 TO 2018
  • COMPANY PROFILES
    • THERMO FISHER SCIENTIFIC, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ROCHE DIAGNOSTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • AGILENT TECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ILLUMINA, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NANOSTRING TECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SARTORIUS AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • FOUNDATION MEDICINE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • HTG MOLECULAR DIAGNOSTICS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • QIAGEN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MERCK
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • PERKINELMER
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report